Avita Medical RCEL 深 滬
已收盤 04-02 16:00:00 美东时间
3.71
-0.060
-1.59%
華盛通- 最 高3.785
- 今 開3.66
- 成交量 9.11万股
- 最 低 3.64
- 昨 收 3.77
- 總市值 1.14亿
- 52周最高 10.29
- 市盈率 靜 --
- 換手率 0.30%
- 52周最低 3.22
- 委 比 -80.58%
- 總股本 3063.18万
- 歷史最高 49.11
- 量 比 0.46
- 振 幅 3.85%
- 歷史最低 3.22
- 每 手 1
- 風險率 1.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
Northland Capital Markets Initiates Coverage On AVITA Medical with Outperform Rating, Announces Price Target of $10
Northland Capital Markets analyst Carl Byrnes initiates coverage on AVITA Medical (NASDAQ:RCEL) with a Outperform rating and announces Price Target of $10.
03-06 02:01
AVITA Medical to Present at TD Cowen 46th Annual Health Care Conference
AVITA Medical to Present at TD Cowen 46th Annual Health Care Conference AVITA Medical Inc. said Interim CEO Cary Vance and CFO David O'Toole will participate in the TD Cowen 46th Annual Health Care Conference in Boston, with a presentation and fireside chat scheduled for March 4 at 8:10 a.m. Pacific
02-24 05:15
Avita Medical Hosts Investor Webinar Briefing
Avita Medical Hosts Investor Webinar Briefing AVITA Medical Inc. has announced it will host an investor webinar briefing and presentation on February 18, 2026, at 2:00 p.m. Pacific Standard Time (February 19, 2026, at 9:00 a.m. Australian Eastern Daylight Time). The event will feature Cary Vance, In
02-13 22:15
Earnings Scheduled For February 12, 2026
Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...
02-12 19:11
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
D. Boral Capital Maintains Buy on AVITA Medical, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $10 price target.
01-26 21:04
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价
今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元
01-16 10:04
